Cover Image
Market Research Report
Product code 
950241

LAMEA Male Infertility Market By Treatment, By Test, By Country, Industry Analysis and Forecast, 2020 - 2026

Published: | KBV Research | 73 Pages | Delivery time: 1-2 business days

Price

Back to Top
LAMEA Male Infertility Market By Treatment, By Test, By Country, Industry Analysis and Forecast, 2020 - 2026
Published: June 30, 2020
KBV Research
Content info: 73 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Latin America, Middle East and Africa Male Infertility Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026).

Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community. High levels of clinically relevant symptoms of depression and anxiety, suicidal thoughts, and a heavy conceptualization of grief impact infertile individuals. Mental health and psychosocial problems and resources need to address key factors of depression, such as poverty, sexual abuse, and infertility.

Growing rates of infertility worldwide and the introduction of assisted reproductive technologies (ARTs) are expected to push the demand for male infertility in the coming years. ARTs address a wide variety of infertility therapies that provide remedies for males facing issues such as reduced sperm count, irregular sperm quality, and poor motility. In addition, ARTs deliver a high success rate compared to drugs. The demand for male infertility is expected to see substantial development in the future due to technical developments in the area of assisted reproductive technology.

Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.

Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.

Scope of the Study

Market Segmentation

By Treatment

  • Assisted Reproductive Technology & Varicocele Surgery and
  • Medication

By Tests

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Sperm Penetration Assay and
  • Other Tests

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Sanofi S.A.
  • Bayer AG
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Endo International PLC
  • Aytu BioScience, Inc.
  • Vitrolife AB
  • SCSA Diagnostics, Inc.
  • Andrology Solutions Limited
  • Halotech DNA SL
  • Intas Pharmaceutical Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Male Infertility Market, by Treatment
    • 1.4.2 LAMEA Male Infertility Market, by Tests
    • 1.4.3 LAMEA Male Infertility Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Male Infertility Market by Treatment

  • 3.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
  • 3.2 LAMEA Medication Market by Country

Chapter 4. LAMEA Male Infertility Market by Test

  • 4.1 LAMEA DNA Fragmentation Technique Market by Country
  • 4.2 LAMEA Oxidative Stress Analysis Market by Country
  • 4.3 LAMEA Computer Assisted Semen Analysis Market by Country
  • 4.4 LAMEA Microscopic Examination Market by Country
  • 4.5 LAMEA Sperm Agglutination Market by Country
  • 4.6 LAMEA Sperm Penetration Assay Market by Country
  • 4.7 LAMEA Other Test Market by Country

Chapter 5. LAMEA Male Infertility Market by Country

  • 5.1 Brazil Male Infertility Market
    • 5.1.1 Brazil Male Infertility Market by Treatment
    • 5.1.2 Brazil Male Infertility Market by Test
  • 5.2 Argentina Male Infertility Market
    • 5.2.1 Argentina Male Infertility Market by Treatment
    • 5.2.2 Argentina Male Infertility Market by Test
  • 5.3 UAE Male Infertility Market
    • 5.3.1 UAE Male Infertility Market by Treatment
    • 5.3.2 UAE Male Infertility Market by Test
  • 5.4 Saudi Arabia Male Infertility Market
    • 5.4.1 Saudi Arabia Male Infertility Market by Treatment
    • 5.4.2 Saudi Arabia Male Infertility Market by Test
  • 5.5 South Africa Male Infertility Market
    • 5.5.1 South Africa Male Infertility Market by Treatment
        • 5.5.1.1.1 South Africa Male Infertility Market by Test
  • 5.6 Nigeria Male Infertility Market
    • 5.6.1 Nigeria Male Infertility Market by Treatment
    • 5.6.2 Nigeria Male Infertility Market by Test
  • 5.7 Rest of LAMEA Male Infertility Market
    • 5.7.1 Rest of LAMEA Male Infertility Market by Treatment
    • 5.7.2 Rest of LAMEA Male Infertility Market by Test

Chapter 6. Company Profiles

  • 6.1 Sanofi S.A.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 Bayer AG
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cadila Healthcare Ltd. (Zydus Cadila)
    • 6.3.1 Company Overview
    • 6.3.1 Financial Analysis
    • 6.3.2 Regional Analysis
    • 6.3.3 Research & Development Expense
  • 6.4 Endo International PLC
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 Aytu BioScience, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional Analysis
    • 6.5.4 Research & Development Expenses
    • 6.5.5 Recent strategies and developments:
      • 6.5.5.1 Acquisition and Mergers:
      • 6.5.5.2 Partnerships, Collaborations, and Agreements:
  • 6.6 Vitrolife AB
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Regional Analysis
    • 6.6.4 Research & Development Expenses
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 SCSA Diagnostics, Inc.
    • 6.7.1 Company Overview
  • 6.8 Andrology Solutions Limited
    • 6.8.1 Company Overview
  • 6.9 Halotech DNA SL
    • 6.9.1 Company Overview
  • 6.1 Intas Pharmaceutical Ltd.
    • 6.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 4 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 5 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 6 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 7 LAMEA MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 8 LAMEA MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 9 LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 10 LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 11 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 14 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 15 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 16 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 17 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 LAMEA OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 24 LAMEA OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 25 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 BRAZIL MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 28 BRAZIL MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 29 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 30 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 31 BRAZIL MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 32 BRAZIL MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 33 ARGENTINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 34 ARGENTINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 35 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 36 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 37 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 38 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 39 UAE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 40 UAE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 41 UAE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 42 UAE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 43 UAE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 44 UAE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 45 SAUDI ARABIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 46 SAUDI ARABIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 47 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 48 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 49 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 50 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 51 SOUTH AFRICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 52 SOUTH AFRICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 53 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 54 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 55 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 56 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 57 NIGERIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 58 NIGERIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 59 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 60 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 61 NIGERIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 62 NIGERIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 63 REST OF LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
  • TABLE 64 REST OF LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
  • TABLE 65 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
  • TABLE 66 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
  • TABLE 67 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
  • TABLE 68 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
  • TABLE 69 KEY INFORMATION - SANOFI S.A.
  • TABLE 70 KEY INFORMATION - BAYER AG
  • TABLE 71 KEY INFORMATION - CADILA HEALTHCARE LTD.
  • TABLE 72 KEY INFORMATION - ENDO INTERNATIONAL PLC
  • TABLE 73 KEY INFORMATION - AYTU BIOSCIENCE, INC.
  • TABLE 74 KEY INFORMATION - VITROLIFE AB
  • TABLE 75 KEY INFORMATION - SCSA DIAGNOSTICS, INC.
  • TABLE 76 KEY INFORMATION - ANDROLOGY SOLUTIONS LIMITED
  • TABLE 77 KEY INFORMATION - HALOTECH DNA SL
  • TABLE 78 KEY INFORMATION - INTAS PHARMACEUTICAL LTD.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH